Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies

INTRODUCTION: To examine pooled efficacy data from three, large phase III studies comparing mirabegron (50 and 100 mg) with placebo, and pooled safety data including additional mirabegron 25 mg and tolterodine extended release (ER) 4 mg results. METHODS: This prespecified pooled analysis of three ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Nitti, V W, Khullar, V, Kerrebroeck, P, Herschorn, S, Cambronero, J, Angulo, J C, Blauwet, M B, Dorrepaal, C, Siddiqui, E, Martin, N E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752932/
https://www.ncbi.nlm.nih.gov/pubmed/23692526
http://dx.doi.org/10.1111/ijcp.12194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752932/
https://www.ncbi.nlm.nih.gov/pubmed/23692526
http://dx.doi.org/10.1111/ijcp.12194

Ejemplares similares